当前位置: 首页 > 期刊 > 《中国当代医药》 > 2016年第4期
编号:12755815
血脂、脂蛋白相关磷脂酶A2与糖尿病视网膜病变关系的研究进展(4)
http://www.100md.com 2016年2月5日 中国当代医药 2016年第4期
     [20] Malecki MT,Osmenda G,Walus-Miarka M,et al.Retinopathy in type 2 diabetes mellitus is associated with increased intima-media thickness and endothelial dysfunction[J].Eur J Clin Invest,2008,38(12):925-930.

    [21] Tikellis G,Anuradha S,Klein R,et al.Association between physical activity and retinal microvascular signs:the Atherosclerosis Risk in Communities (ARIC) Study[J].Microcirculation,2010,17(5):381.

    [22] 徐玉善,王曦,李红.2型糖尿病周围神经病变与颈动脉内膜中层厚度的关系探讨[J].昆明医学院学报,2009, 30(1):46-49.

    [23] Moreno PR,Fuster V.New aspects in the pathogenesis of diabetic atherothrombosis[J].J Am Coll Cardiol,2004,44(12):2293-2300.

    [24] Iwase M,Sonoki K,Sasaki N,et al.Lysophosphatidylcholine contents in plasma LDL in patients with type 2 diabetes mellitus:relation with lipoprotein-associated phospholipase a2 and effects of simvastatin treatment[J].Atherosclerosis,2008,196(2):931-936.

    [25] Staurenghi G,Ye L,Magee MH,et al.Darapladib,a lipoprotein-associated phospholipase A2 inhibitor,in diabetic macular edema:a 3-month placebo-controlled study[J].Ophthalmology,2015,122(5):990-996.

    (收稿日期:2015-12-09 本文编辑:祁海文), 百拇医药(朱红云 鞠海兵)
上一页1 2 3 4